000 01388 a2200421 4500
005 20250517002609.0
264 0 _c20160830
008 201608s 0 0 eng d
022 _a1559-1182
024 7 _a10.1007/s12035-014-8980-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEsteves, A R
245 0 0 _aThe Upshot of LRRK2 Inhibition to Parkinson's Disease Paradigm.
_h[electronic resource]
260 _bMolecular neurobiology
_cDec 2015
300 _a1804-1820 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAutophagy
_xphysiology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLeucine-Rich Repeat Serine-Threonine Protein Kinase-2
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMitochondria
_xmetabolism
650 0 4 _aNeurons
_xmetabolism
650 0 4 _aParkinson Disease
_xmetabolism
650 0 4 _aPhosphorylation
650 0 4 _aProtein Serine-Threonine Kinases
_xmetabolism
650 0 4 _aProtein Transport
650 0 4 _aProteolysis
700 1 _aG-Fernandes, M
700 1 _aSantos, D
700 1 _aJanuário, C
700 1 _aCardoso, S M
773 0 _tMolecular neurobiology
_gvol. 52
_gno. 3
_gp. 1804-1820
856 4 0 _uhttps://doi.org/10.1007/s12035-014-8980-6
_zAvailable from publisher's website
999 _c24352029
_d24352029